Sign Out
Symptomatic response to rabeprazole does not preclude the presence of gastric malignancy. Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with benzimidazoles to which group rabeprazole also belongs.
Rabeprazole, like other proton-pump inhibitors, has potential to cause gastric carcinoids but the studies have not been conclusive.
